Skip to main content
. 2017 Nov 22;61(12):e01350-17. doi: 10.1128/AAC.01350-17

FIG 3.

FIG 3

Percent susceptibility of ICU patient respiratory P. aeruginosa isolates (n = 156) to ceftolozane-tazobactam (pink bar) compared to that to β-lactams alone (orange bars) or in combination with ciprofloxacin (blue bars) or tobramycin (green bars). Definitions: CAZ, ceftazidime; C/T, ceftolozane-tazobactam; FEP, cefepime; MEM, meropenem; TZP, piperacillin-tazobactam.